| 946136-58-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• CAS: 946136-58-9
• 化学式: C₂₂H₂₇NO₂
• 分子量: 337.462
• InChiKey: ZGVRZBKVYSDBRA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.65
• 重原子数：
  25.0
• 可旋转键数：
  7.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  38.33
• 氢给体数：
  1.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 24.0h， 以72%的产率得到N-[3-(3-phenylmethoxyphenyl)propyl]cyclohexanamine
  参考文献：
  名称：

  Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads

  摘要：

  We have identified macrocyclic inhibitors of the aspartic protease BACE, implicated in the etiology of Alzheimer's disease. An X-ray structure of screening hit 1 in the BACE active site revealed a hairpin conformation suggesting that constrained macrocyclic derivatives may also bind there. Several of the analogs we prepared were >100x more potent than 1, such as 7 (5 nM K(i)). (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.03.097
• 作为产物：
  描述：

  3-(3-benzyloxy-phenyl)-propionyl chloride 、 环己胺 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 以94%的产率得到
  参考文献：
  名称：

  Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads

  摘要：

  We have identified macrocyclic inhibitors of the aspartic protease BACE, implicated in the etiology of Alzheimer's disease. An X-ray structure of screening hit 1 in the BACE active site revealed a hairpin conformation suggesting that constrained macrocyclic derivatives may also bind there. Several of the analogs we prepared were >100x more potent than 1, such as 7 (5 nM K(i)). (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.03.097

文献信息

• MACROCYCLE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE)
  申请人：Baxter W. Ellen

  公开号：US20070232630A1

  公开（公告）日：2007-10-04

  The present invention is directed to macrocycle derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the invention are inhibitors of β-secretase, also known as β-site cleaving enzyme and BACE, BACE1, Asp2 and memapsin2.

  本发明涉及大环衍生物，含有它们的药物组合物以及它们在治疗阿尔茨海默病（AD）及相关疾病中的应用。本发明的化合物是β-分泌酶的抑制剂，也被称为β-位点裂解酶和BACE、BACE1、Asp2和memapsin2。